mirtazapine has been researched along with Lymphoma, T Cell, Peripheral in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bromberg, H | 1 |
| Chang, Y | 1 |
| Craig, D | 1 |
| Peña, M | 1 |
| Presas-Rodríguez, S | 1 |
| Ribera, JM | 1 |
2 other studies available for mirtazapine and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Pruritic Manifestation of Peripheral T Cell Lymphoma Effectively Managed with Mirtazapine: A Case Report.
Topics: Aged; Antidepressive Agents, Tricyclic; Humans; Lymphoma, T-Cell, Peripheral; Male; Mirtazapine; Pru | 2020 |
Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma.
Topics: Aged; Drug Combinations; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, T-Cell, Peri | 2019 |